Supplemental material
Open access
4,613
Views
7
CrossRef citations to date
0
Altmetric
Zoster
Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review
Nikolaos Giannelosa GSK, Value Evidence, Wavre, BelgiumCorrespondence[email protected]
https://orcid.org/0000-0001-9130-4744View further author information
Cheryl Ngb GSK, Value Evidence, Singapore, Singapore
https://orcid.org/0000-0002-1707-2305View further author information
Desmond Currana GSK, Value Evidence, Wavre, Belgium
https://orcid.org/0000-0002-7423-0111View further author information
Article: 2168952
|
Received 16 Sep 2022, Accepted 12 Jan 2023, Published online: 14 Mar 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.